211 related articles for article (PubMed ID: 18006891)
1. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.
Lubamba B; Lecourt H; Lebacq J; Lebecque P; De Jonge H; Wallemacq P; Leal T
Am J Respir Crit Care Med; 2008 Mar; 177(5):506-15. PubMed ID: 18006891
[TBL] [Abstract][Full Text] [Related]
2. Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice.
Lubamba B; Lebacq J; Reychler G; Marbaix E; Wallemacq P; Lebecque P; Leal T
Eur Respir J; 2011 Jan; 37(1):72-8. PubMed ID: 20562123
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 5 inhibitors and cystic fibrosis: correcting chloride channel dysfunction.
Clarke LL
Am J Respir Crit Care Med; 2008 Mar; 177(5):469-70. PubMed ID: 18296466
[No Abstract] [Full Text] [Related]
4. Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice.
Dhooghe B; Noël S; Bouzin C; Behets-Wydemans G; Leal T
PLoS One; 2013; 8(10):e77314. PubMed ID: 24204804
[TBL] [Abstract][Full Text] [Related]
5. Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice.
Lubamba B; Lebacq J; Lebecque P; Vanbever R; Leonard A; Wallemacq P; Leal T
Am J Respir Crit Care Med; 2009 Jun; 179(11):1022-8. PubMed ID: 19299496
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
Dormer RL; Harris CM; Clark Z; Pereira MM; Doull IJ; Norez C; Becq F; McPherson MA
Thorax; 2005 Jan; 60(1):55-9. PubMed ID: 15618584
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice.
Lubamba B; Huaux F; Lebacq J; Marbaix E; Dhooghe B; Panin N; Wallemacq P; Leal T
J Cyst Fibros; 2012 Jul; 11(4):266-73. PubMed ID: 22503062
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vectorial ion transport in primary murine airway and human sinonasal air-liquid interface cultures, models for studies of cystic fibrosis, and other airway diseases.
Zhang S; Fortenberry JA; Cohen NA; Sorscher EJ; Woodworth BA
Am J Rhinol Allergy; 2009; 23(2):149-52. PubMed ID: 19401039
[TBL] [Abstract][Full Text] [Related]
9. Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.
Noël S; Wilke M; Bot AG; De Jonge HR; Becq F
J Pharmacol Exp Ther; 2008 Jun; 325(3):1016-23. PubMed ID: 18309088
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacodynamics and pharmacokinetics of vardenafil in patients with erectile dysfunction].
Jin J; Guo Y
Zhonghua Nan Ke Xue; 2004 Sep; 10(9):711-6. PubMed ID: 15497717
[TBL] [Abstract][Full Text] [Related]
11. [Effective and safe use of Levitra (Vardenafil) for treatment of erectile dysfunction].
Mazo EB; Gamidov SI; Ovchinnikov RI
Urologiia; 2004; (3):58-66. PubMed ID: 15199819
[No Abstract] [Full Text] [Related]
12. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
13. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
[TBL] [Abstract][Full Text] [Related]
14. The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype.
Shon JH; Ku HY; Bae SY; Oh MK; Yeo CW; Bae SK; Shin JG
Pharmacogenet Genomics; 2011 Dec; 21(12):820-8. PubMed ID: 21934637
[TBL] [Abstract][Full Text] [Related]
15. Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms.
Noel S; Panin N; Beka M; Dhooghe B; Huaux F; Leal T
Clin Sci (Lond); 2017 Jun; 131(11):1107-1121. PubMed ID: 28196856
[TBL] [Abstract][Full Text] [Related]
16. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence.
Traish A; Kim N
J Sex Med; 2008 Jul; 5(7):1762-8; discussion 1768-9. PubMed ID: 18221281
[No Abstract] [Full Text] [Related]
17. Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect.
Robert R; Carlile GW; Pavel C; Liu N; Anjos SM; Liao J; Luo Y; Zhang D; Thomas DY; Hanrahan JW
Mol Pharmacol; 2008 Feb; 73(2):478-89. PubMed ID: 17975008
[TBL] [Abstract][Full Text] [Related]
18. The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.
Smith SN; Middleton PG; Chadwick S; Jaffe A; Bush KA; Rolleston S; Farley R; Delaney SJ; Wainwright B; Geddes DM; Alton EW
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):129-34. PubMed ID: 9870926
[TBL] [Abstract][Full Text] [Related]
19. Effect of apical chloride concentration on the measurement of responses to CFTR modulation in airway epithelia cultured from nasal brushings.
Bratcher PE; Yadav S; Shaughnessy CA; Thornell IM; Zeitlin PL
Physiol Rep; 2020 Oct; 8(19):e14603. PubMed ID: 33038073
[TBL] [Abstract][Full Text] [Related]
20. Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.
Carson CC; Hatzichristou DG; Carrier S; Lording D; Lyngdorf P; Aliotta P; Auerbach S; Murdock M; Wilkins HJ; McBride TA; Colopy MW;
BJU Int; 2004 Dec; 94(9):1301-9. PubMed ID: 15610110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
